Successful drug development in today’s fast-paced Life Sciences industry goes beyond just meeting regulatory requirements. It calls for agile strategies, efficient team structures, and a proactive approach across every stage, from early clinical planning to the final commercial rollout. To keep pace, companies need a partner who can navigate scientific and operational complexities. Demberg PharmaSolutions (DPS) has evolved into that partner. Once primarily known for its strength in quality systems and regulatory guidance, the firm now delivers full-spectrum consulting across the entire product lifecycle. With over 35 years of experience in the life sciences and regulatory environment, founder and president Natasha Demberg leads DPS in helping pharmaceutical, biotech, cosmetic, and healthcare organizations streamline operations and maintain compliance across all stages of product lifecycle starting at early development stage, such as Phase 1 clinical study. DPS guides their partners from early-stage clinical trials through to commercialization, process alignment, and strategic organizational design, adopted to every step. Whether managing global trials or restructuring internal workflows, DPS ensures that science, strategy, and operational structure are fully aligned, driving sustainable success in an increasingly complex development landscape. It has built flexible quality systems that support clinical trials from the outset, allowing for a smooth progression into commercialization without the burden of costly system changes. This approach saves time and resources, setting a strong foundation for long-term success. “Our goal is not just to meet the standard but to help clients build systems and teams that are scalable and future-ready,” says Demberg. By embedding compliance with key regulatory GxP standards, including FDA, EMA, and Health Canada, into its processes, DPS helps clients stay ahead of regulatory demands while advancing their growth goals. Its quality support evolves with each stage of development, from early-phase trials to post-market surveillance, ensuring a tailored, phase-specific approach at every step..

Plum Clinical Solutions is a boutique consultancy helping early-stage and growing biotech companies navigate clinical supply management’s intricate operational, regulatory, and technical demands. The firm specializes in forecasting and planning of clinical supplies, manufacturing and labeling of clinical supplies, setup of the IRT and inventory management, global logistics and distribution, and specialty areas such as logistics for ultra-cold chain or controlled substances, offering comprehensive, hands-on support across the entire clinical supply lifecycle. Clare Plumtree, founder and principal consultant at Plum Clinical Solutions, is at the heart of the consultancy. A pharmaceutical industry veteran with over 25 years of experience, she has focused on clinical supplies for the past 15 years. After her previous company was acquired and the team was let go, Plumtree transitioned into consultancy and identified a crucial market gap. Small and mid-sized biotech firms often struggle to meet rising clinical supply demands because they lack the necessary infrastructure and headcount. “I often come in when complexity is growing faster than headcount,” says Plumtree. “Many smaller companies try to manage supply responsibilities by distributing them across project managers or CMC leads, but as the study scales, that approach quickly becomes unmanageable.” Flexible, Embedded Clinical Supply Leadership Having worked across multiple organizations and study phases, she founded Plum Clinical Solutions to fill a growing need for hands-on, technical supply leadership in smaller, fast-moving biotech environments. Plumtree works directly with clients as a fractional FTE or embedded consultant, providing the dual advantage of strategic oversight and hands-on execution. Each engagement begins with a scoping discussion to assess needs, define deliverables, and agree on the working model, hourly or retainer, ensuring alignment before work begins. Her cross-functional background in clinical operations, CMC, and logistics enables seamless coordination between internal teams and external vendors. The model is built on flexibility, accountability, and deep subject-matter expertise, offering biotech organizations a single, experienced point of contact throughout each engagement..